After we have built enough confidence that the lead formulation will provide adequate bioavailability, we progress into the trajectory toward clinical production.

For each of the formulation approaches we are offering, we have established alliances with reputable local CDMOs but we are happy to partner with CDMOs of your choice as well. Harpago guides the technology transfer process all the way through.